Dawn L. DeMeo

ORCID: 0000-0001-9653-0636
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Chronic Obstructive Pulmonary Disease (COPD) Research
  • Epigenetics and DNA Methylation
  • Asthma and respiratory diseases
  • Neonatal Respiratory Health Research
  • Genetic Associations and Epidemiology
  • Pediatric health and respiratory diseases
  • Respiratory Support and Mechanisms
  • Birth, Development, and Health
  • Bioinformatics and Genomic Networks
  • Gene expression and cancer classification
  • Pulmonary Hypertension Research and Treatments
  • Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis
  • RNA modifications and cancer
  • Air Quality and Health Impacts
  • Delphi Technique in Research
  • Childhood Cancer Survivors' Quality of Life
  • Cancer Genomics and Diagnostics
  • Pharmacogenetics and Drug Metabolism
  • Protease and Inhibitor Mechanisms
  • Cancer-related gene regulation
  • Genomics and Rare Diseases
  • Health, Environment, Cognitive Aging
  • Genetic Mapping and Diversity in Plants and Animals
  • Hormonal Regulation and Hypertension
  • Gene Regulatory Network Analysis

Brigham and Women's Hospital
2016-2025

Harvard University
2016-2025

Harvard University Press
2012-2024

Woman's Hospital
2023-2024

Boston University
2006-2022

VA Boston Healthcare System
2022

Harvard Pilgrim Health Care
2022

Beth Israel Deaconess Medical Center
2004-2021

Washington University in St. Louis
2020

Pulmonary and Critical Care Associates
2011-2018

Daniel Taliun Daniel Harris Michael D. Kessler Jedidiah Carlson Zachary A. Szpiech and 95 more Raúl Torres Sarah A. Gagliano Taliun André Corvelo Stephanie M. Gogarten Hyun Min Kang Achilleas Pitsillides Jonathon LeFaive Seung‐been Lee Xiaowen Tian Brian L. Browning Sayantan Das Anne‐Katrin Emde Wayne E. Clarke Douglas P. Loesch Amol C. Shetty Thomas W. Blackwell Albert V. Smith Quenna Wong Xiaoming Liu Matthew P. Conomos Dean Bobo François Aguet Christine M. Albert Álvaro Alonso Kristin Ardlie Dan E. Arking Stella Aslibekyan Paul L. Auer John Barnard R. Graham Barr Lucas Barwick Lewis C. Becker Rebecca Beer Emelia J. Benjamin Lawrence F. Bielak John Blangero Michael Boehnke Donald W. Bowden Jennifer A. Brody Esteban G. Burchard Brian E. Cade James F. Casella Brandon Chalazan Daniel I. Chasman Yii‐Der Ida Chen Michael H. Cho Seung Hoan Choi Mina K. Chung Clary B. Clish Adolfo Correa Joanne E. Curran Brian Custer Dawood Darbar Michelle Daya Mariza de Andrade Dawn L. DeMeo Susan K. Dutcher Patrick T. Ellinor Leslie Emery Celeste Eng Diane Fatkin Tasha E. Fingerlin Lukas Forer Myriam Fornage Nora Franceschini Christian Fuchsberger Stephanie M. Fullerton Søren Germer Mark T. Gladwin Daniel J. Gottlieb Xiuqing Guo Michael E. Hall Jiang He Nancy L. Heard‐Costa Susan R. Heckbert Marguerite R. Irvin Jill M. Johnsen Andrew D. Johnson Robert C. Kaplan Sharon L. R. Kardia Tanika N. Kelly Shannon Kelly Eimear E. Kenny Douglas P. Kiel Robert Klemmer Barbara A. Konkle Charles Kooperberg Anna Köttgen Leslie A. Lange Jessica Lasky‐Su Daniel Levy Xihong Lin Keng‐Han Lin Chunyu Liu Ruth J. F. Loos

Abstract The Trans-Omics for Precision Medicine (TOPMed) programme seeks to elucidate the genetic architecture and biology of heart, lung, blood sleep disorders, with ultimate goal improving diagnosis, treatment prevention these diseases. initial phases focused on whole-genome sequencing individuals rich phenotypic data diverse backgrounds. Here we describe TOPMed goals design as well available resources early insights obtained from sequence data. include a variant browser, genotype...

10.1038/s41586-021-03205-y article EN cc-by Nature 2021-02-10

<h3>Importance</h3> Airflow obstruction on spirometry is universally used to define chronic obstructive pulmonary disease (COPD), and current or former smokers without airflow may assume that they are free. <h3>Objective</h3> To identify clinical radiologic evidence of smoking-related in a cohort who did not meet spirometric criteria for COPD, whom we adopted the discarded label Global Initiative Obstructive Lung Disease (GOLD) 0. <h3>Design, Setting, Participants</h3> Individuals from...

10.1001/jamainternmed.2015.2735 article EN JAMA Internal Medicine 2015-06-22

Although all human tissues carry out common processes, are distinguished by gene expression patterns, implying that distinct regulatory programs control tissue specificity. In this study, we investigate and regulation across 38 profiled in the Genotype-Tissue Expression project. We find network edges (transcription factor to target connections) have higher specificity than nodes (genes) regulating factors) less likely be expressed a tissue-specific manner as compared their targets (genes)....

10.1016/j.celrep.2017.10.001 article EN cc-by-nc-nd Cell Reports 2017-10-01

Genetic variants influencing lung function in children and adults may ultimately lead to the development of chronic obstructive pulmonary disease (COPD), particularly high-risk groups.We tested for an association between single-nucleotide polymorphisms (SNPs) gene encoding matrix metalloproteinase 12 (MMP12) a measure (prebronchodilator forced expiratory volume 1 second [FEV(1)]) more than 8300 subjects seven cohorts that included adults. Within Normative Aging Study (NAS), cohort initially...

10.1056/nejmoa0904006 article EN New England Journal of Medicine 2009-12-17
Phuwanat Sakornsakolpat Dmitry Prokopenko Maxime Lamontagne Nicola Reeve Anna L. Guyatt and 95 more Victoria E. Jackson Nick Shrine Dandi Qiao Traci M. Bartz Deog Kyeom Kim Mi Kyeong Lee Jeanne C. Latourelle Xingnan Li Jarrett D. Morrow Ma’en Obeidat Annah B. Wyss Per Bakke R. Graham Barr Terri H. Beaty Steven A. Belinsky Guy Brusselle James D. Crapo Kim de Jong Dawn L. DeMeo Tasha E. Fingerlin Sina A. Gharib Amund Gulsvik Ian P. Hall John E. Hokanson Woo Jin Kim David A. Lomas Stephanie J. London Deborah A. Meyers George O'connor Stephen I. Rennard David A. Schwartz Paweł Śliwiński David Sparrow David P. Strachan Ruth Tal‐Singer Yohannes Tesfaigzi Jørgen Vestbo Judith M. Vonk Jae‐Joon Yim Xiaobo Zhou Yohan Bossé Ani Manichaikul Lies Lahousse Edwin K. Silverman H. Marike Boezen Louise V. Wain Martin D. Tobin Brian D. Hobbs Michael H. Cho Nick Shrine Anna L. Guyatt Chiara Batini Jing Hua Zhao Matthias Wielscher Stefan Weiß Katherine A. Kentistou James P. Cook Jennie Hui Stefan Karrasch Medea Imboden Sarah E. Harris Jonathan Marten Stefan Enroth Shona M. Kerr Ida Surakka Véronique Vitart Terho Lehtimäki Ralf Ewert Christian Gieger Georg Homuth Peter K. Joshi Claudia Langenberg Lars Lind Jian’an Luan Anubha Mahajan Alison D. Murray David J. Porteous Rajesh Rawal Blair H. Smith Paul R. H. J. Timmers Olli Raitakari Mika Kähönen Ozren Polašek Ulf Gyllensten Igor Rudan Ian J. Deary Nicole Probst‐Hensch Holger Schulz Anthony James James F. Wilson Beate Stubbe Eleftheria Zeggini Marjo‐Riitta Järvelin Nicholas J. Wareham Caroline Hayward

10.1038/s41588-018-0342-2 article EN Nature Genetics 2019-02-25

Sex differences manifest in many diseases and may drive sex-specific therapeutic responses. To understand the molecular basis of sex differences, we evaluated sex-biased gene regulation by constructing sample-specific regulatory networks 29 human healthy tissues using 8,279 whole-genome expression profiles from Genotype-Tissue Expression (GTEx) project. We find network structures each tissue. Even though most transcription factors (TFs) are not differentially expressed between males females,...

10.1016/j.celrep.2020.107795 article EN cc-by-nc-nd Cell Reports 2020-06-01

The number of female smokers developing chronic obstructive pulmonary disease (COPD) is rapidly increasing, but whether or not there exists a differential susceptibility by gender remains controversial.How smoking behaviour and subsequent lung function reduction differed was examined in study including 954 subjects with COPD 955 without COPD. focused on two subgroups: <60 years age (early-onset group, n=316) <20 pack-years (low exposure n=241).In the low had lower forced expiratory volume 1...

10.1136/thx.2009.122002 article EN Thorax 2010-06-01

The impact of cigarette smoking can persist for extended periods following cessation and may involve epigenetic reprogramming. Changes in DNA methylation associated with help to identify molecular pathways that contribute the latency between exposure disease onset. Cross-sectional cohort data from subjects International COPD Genetics Network (n = 1085) Boston Early-Onset study 369) were analyzed as discovery replication cohorts, respectively. Genome-wide on 27 578 CpG sites 14 475 genes...

10.1093/hmg/dds135 article EN Human Molecular Genetics 2012-04-06

Preserved Ratio Impaired Spirometry (PRISm), defined as a reduced FEV1 in the setting of preserved FEV1/FVC ratio, is highly prevalent and associated with increased respiratory symptoms, systemic inflammation, mortality. Studies investigating quantitative chest tomographic features, genetic associations, subtypes PRISm subjects have not been reported. Data from current former smokers enrolled COPDGene (n = 10,192), an observational, cross-sectional study which recruited aged 45–80 ≥10 pack...

10.1186/s12931-014-0089-y article EN cc-by Respiratory Research 2014-08-06
Daniel Taliun Daniel Harris Michael D. Kessler Jedidiah Carlson Zachary A. Szpiech and 95 more Raúl Torres Sarah A. Gagliano Taliun André Corvelo Stephanie M. Gogarten Hyun Min Kang Achilleas Pitsillides Jonathon LeFaive Seung‐been Lee Xiaowen Tian Brian L. Browning Sayantan Das Anne‐Katrin Emde Wayne E. Clarke Douglas P. Loesch Amol C. Shetty Thomas W. Blackwell Quenna Wong François Aguet Christine M. Albert Álvaro Alonso Kristin Ardlie Stella Aslibekyan Paul L. Auer John Barnard R. Graham Barr Lewis C. Becker Rebecca Beer Emelia J. Benjamin Lawrence F. Bielak John Blangero Michael Boehnke Donald W. Bowden Jennifer A. Brody Esteban G. Burchard Brian E. Cade James F. Casella Brandon Chalazan Yii‐Der Ida Chen Michael H. Cho Seung Hoan Choi Mina K. Chung Clary B. Clish Adolfo Correa Joanne E. Curran Brian Custer Dawood Darbar Michelle Daya Mariza de Andrade Dawn L. DeMeo Susan K. Dutcher Patrick T. Ellinor Leslie Emery Diane Fatkin Lukas Forer Myriam Fornage Nora Franceschini Christian Fuchsberger Stephanie M. Fullerton Søren Germer Mark T. Gladwin Daniel J. Gottlieb Xiuqing Guo Michael E. Hall Jiang He Nancy L. Heard‐Costa Susan R. Heckbert Marguerite R. Irvin Jill M. Johnsen Andrew D. Johnson Sharon L. R. Kardia Tanika N. Kelly Shannon Kelly Eimear E. Kenny Douglas P. Kiel Robert Klemmer Barbara A. Konkle Charles Kooperberg Anna Köttgen Leslie A. Lange Jessica Lasky‐Su Daniel Levy Xihong Lin Keng‐Han Lin Chunyu Liu Ruth J. F. Loos Lori Garman Robert E. Gerszten Steven A. Lubitz Kathryn L. Lunetta Angel C. Y. Mak Ani Manichaikul Alisa K. Manning Rasika A. Mathias David D. McManus Stephen T. McGarvey

Summary paragraph The Trans-Omics for Precision Medicine (TOPMed) program seeks to elucidate the genetic architecture and disease biology of heart, lung, blood, sleep disorders, with ultimate goal improving diagnosis, treatment, prevention. initial phases focus on whole genome sequencing individuals rich phenotypic data diverse backgrounds. Here, we describe TOPMed goals design as well resources early insights from sequence data. include a variant browser, genotype imputation panel, sharing...

10.1101/563866 preprint EN cc-by bioRxiv (Cold Spring Harbor Laboratory) 2019-03-06
Emily S. Wan Spyridon Fortis Elizabeth A. Regan John E. Hokanson MeiLan K. Han and 95 more Richard Casaburi Barry J. Make James D. Crapo Dawn L. DeMeo Edwin K. Silverman James D. Crapo Edwin K. Silverman Barry J. Make Elizabeth A. Regan Terri H. Beaty Ferdouse Begum Peter J. Castaldi Michael H. Cho Dawn L. DeMeo Adel R. Boueiz Marilyn G. Foreman Eitan Halper-Stromberg Lystra P. Hayden Craig P. Hersh Jacqueline B. Hetmanski Brian D. Hobbs John E. Hokanson Nan M. Laird Christoph Lange Sharon M. Lutz Merry‐Lynn McDonald Margaret M. Parker Dandi Qiao Elizabeth A. Regan Edwin K. Silverman Emily S. Wan Sungho Won Phuwanat Sakornsakolpat Dmitry Prokopenko Mustafa Al Qaisi Harvey O. Coxson Teresa Gray MeiLan K. Han Eric A. Hoffman Stephen M. Humphries Francine L. Jacobson Philip F. Judy Ella A. Kazerooni Alex Kluiber David A. Lynch John D. Newell Elizabeth A. Regan James C. Ross Raúl San Jośe Estépar Joyce Schroeder Jered Sieren Douglas Stinson Berend C. Stoel Juerg Tschirren Edwin J.R. van Beek Bram van Ginneken Eva M. van Rikxoort George R. Washko Carla G. Wilson Robert L. Jensen Douglas Curran‐Everett Jim Crooks Camille M. Moore Matthew Strand Carla G. Wilson John E. Hokanson J A Hughes Gregory L. Kinney Sharon M. Lutz Katherine Pratte Kendra A. Young Surya P. Bhatt Jessica Bon MeiLan K. Han Barry J. Make Carlos Martínez Susan Murray Elizabeth A. Regan Xavier Soler Carla G. Wilson Russell P. Bowler Katerina Kechris Farnoush Banaei‐Kashani Jeffrey L. Curtis Cristina Martínez Perry G. Pernicano Nicola A. Hanania Philip Alapat Mustafa Atik Venkata Bandi Aladin M. Boriek Kalpatha Guntupalli Elizabeth Guy Arun C. Nachiappan Amit Parulekar

Increasing awareness of the prevalence and significance Preserved Ratio Impaired Spirometry (PRISm), alternatively known as restrictive or Global Initiative for Chronic Obstructive Lung Disease (GOLD)-unclassified spirometry, has expanded body knowledge on cross-sectional risk factors. However, longitudinal studies PRISm remain limited.

10.1164/rccm.201804-0663oc article EN American Journal of Respiratory and Critical Care Medicine 2018-06-06
Jeong H. Yun Andrew Lamb Robert Chase Dave Singh Margaret M. Parker and 95 more Aabida Saferali Jørgen Vestbo Ruth Tal‐Singer Peter J. Castaldi Edwin K. Silverman Craig P. Hersh James D. Crapo Edwin K. Silverman Barry J. Make Elizabeth A. Regan Terri H. Beaty Ferdouse Begum Robert Busch Peter J. Castaldi Michael Cho Dawn L. DeMeo Adel R. Boueiz Marilyn G. Foreman Eitan Halper-Stromberg Nadia N. Hansel Megan Hardin Lystra P. Hayden Craig P. Hersh Jacqueline B. Hetmanski Brian D. Hobbs John E. Hokanson Nan M. Laird Christoph Lange Sharon M. Lutz Merry‐Lynn McDonald Margaret M. Parker Dandi Qiao Elizabeth A. Regan Stephanie Santorico Edwin K. Silverman Emily S. Wan Sungho Won Mustafa Al Qaisi Harvey O. Coxson Teresa Gray MeiLan K. Han Eric A. Hoffman Steve E. Humphries Francine L. Jacobson Philip F. Judy Ella A. Kazerooni Alex Kluiber David A. Lynch John D. Newell Elizabeth A. Regan James C. Ross Raúl San Jośe Estépar Joyce Schroeder Jered Sieren Douglas R. Stinson Berend C. Stoel Juerg Tschirren Edwin J.R. van Beek Bram van Ginneken Eva M. van Rikxoort George R. Washko Carla G. Wilson Robert T. Jensen D. H. Everett Jim Crooks Camille M. Moore Matthew Strand Carla G. Wilson John E. Hokanson John P. Hughes Gregory L. Kinney Sharon M. Lutz Katherine Pratte Kendra A. Young Jeffrey L. Curtis Cristina Martínez Perry G. Pernicano Nicola A. Hanania Philip Alapat Mustafa Atik Venkata Bandi Aladin M. Boriek Kalpatha Guntupalli Elizabeth Guy Arun C. Nachiappan Amit Parulekar Dawn L. DeMeo Craig P. Hersh Francine L. Jacobson George R. Washko R. Graham Barr John Austin Belinda D’Souza Gregory D. Pearson Anna Rozenshtein

10.1016/j.jaci.2018.04.010 article EN publisher-specific-oa Journal of Allergy and Clinical Immunology 2018-04-28

Growing evidence has linked positive psychological attributes like optimism to a lower risk of poor health outcomes, especially cardiovascular disease. It been demonstrated in randomized trials that can be learned. If associations between and broader outcomes are established, it may lead novel interventions improve public longevity. In the present study, we evaluated association cause-specific mortality women after considering role potential confounding (sociodemographic characteristics,...

10.1093/aje/kww182 article EN American Journal of Epidemiology 2016-12-07
Katherine Lowe Elizabeth A. Regan Antonio Anzueto Erin Austin John H. M. Austin and 95 more Terri H. Beaty Panayiotis V. Benos Christopher J. Benway Surya P. Bhatt Eugene R. Bleecker Sandeep Bodduluri Jessica Bon Aladin M. Boriek Adel R. Boueiz Russell P. Bowler Matthew J. Budoff Richard Casaburi Peter J. Castaldi Jean-Paul Charbonnier Michael H. Cho Alejandro P. Comellas Douglas Conrad Corinne Costa Davis Gerard J. Criner Douglas Curran‐Everett Jeffrey L. Curtis Dawn L. DeMeo Alejandro A. Díaz Mark T. Dransfield Jennifer Dy Ashraf Fawzy Margaret Fleming Eric L. Flenaugh Marilyn G. Foreman Spyridon Fortis Hirut Gebrekristos Sarah Schmidt Grant Philippe Greniér Tian Gu Abhya Gupta MeiLan K. Han Nicola A. Hanania Nadia N. Hansel Lystra P. Hayden Craig P. Hersh Brian D. Hobbs Eric A. Hoffman James C. Hogg John E. Hokanson Karin F. Hoth Albert Hsiao Stephen M. Humphries Kathleen Jacobs Francine L. Jacobson Ella A. Kazerooni V. Kim Woo Jin Kim Gregory L. Kinney Harald Koegler Sharon M. Lutz David A. Lynch Neil R. MacIntye Barry J. Make Nathaniel Marchetti Fernando J. Martínez Diego J. Maselli Anne M. Mathews Meredith C. McCormack Merry‐Lynn McDonald Charlene McEvoy Matthew Moll Sarah S. Molye Susan Murray Hrudaya Nath John D. Newell Mariaelena Occhipinti Matteo Paoletti Trisha M. Parekh Massimo Pistolesi Katherine Pratte Nirupama Putcha M.F. Ragland Joseph M. Reinhardt Stephen I. Rennard Richard Rosiello James C. Ross Harry B. Rossiter Ingo Ruczinski Raúl San Jośe Estépar Frank C. Sciurba Jessica C. Sieren Harjinder Singh Xavier Soler Robert M. Steiner Matthew Strand William W. Stringer Ruth Tal‐Singer Byron Thomashow Gonzalo Vegas‐Sánchez‐Ferrero John W. Walsh

Chronic obstructive pulmonary disease (COPD) remains a major cause of morbidity and mortality. Present-day diagnostic criteria are largely based solely on spirometric criteria. Accumulating evidence has identified substantial number individuals without COPD who suffer from respiratory symptoms and/or increased There is clear need for an expanded definition that linked to physiologic, structural (computed tomography [CT]) clinical disease. Using data the Genetic Epidemiology study (COPDGene

10.15326/jcopdf.6.5.2019.0149 article EN Chronic Obstructive Pulmonary Diseases Journal of the COPD Foundation 2019-01-01
Coming Soon ...